人工器官市場規模、佔有率和成長分析(按器官類型、固定方法、材料、最終用戶和地區分類)—產業預測(2026-2033 年)
市場調查報告書
商品編碼
1896091

人工器官市場規模、佔有率和成長分析(按器官類型、固定方法、材料、最終用戶和地區分類)—產業預測(2026-2033 年)

Artificial Organs Market Size, Share, and Growth Analysis, By Organ Type (Artificial kidney, Artificial liver), By Fixation (Implantable, Wearable), By End-User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 182 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球人工器官市場預計到 2024 年將達到 307.5 億美元,到 2025 年將達到 331.8 億美元,到 2033 年將達到 609.6 億美元,預測期(2026-2033 年)的複合年成長率為 7.9%。

全球人工器官市場正經歷顯著成長,其主要驅動力是人口老化以及65歲以上人口對器官移植需求的不斷成長。該年齡層尤其容易出現移植後併發症,這進一步增加了對先進人工器官設備的需求。隨著病患需求的增加,移植等待名單不斷擴大,各方正積極進行創新工作,以提高器官移植體系的效率和課責。此外,3D生物列印技術的進步至關重要,它能夠製造出排斥風險極低的人工器官。同時,人工智慧的融合正在革新製造程序,並實現個人化的器官和供體評估,從而幫助患者做出關於移植方案的決策流程。這一蓬勃發展的局面凸顯了醫療產業中一個快速成長的領域。

全球人工器官市場促進因素

腎衰竭、心臟病和肝功能障礙等慢性疾病的日益增多是推動人工器官市場發展的主要因素。隨著越來越多的人面臨與器官相關的健康挑戰,對透析機、人工心臟和肝臟支持系統等人工解決方案的需求持續成長。人口老化和人們對提高生活品質日益成長的關注進一步加劇了這一趨勢,凸顯了創新救生干預措施的緊迫性。隨著越來越多的患者尋求有效的解決方案來控制病情,人工器官市場預計將顯著成長,因為它滿足了全球一項重要的醫療需求。

全球人工器官市場面臨的限制因素

儘管人工器官領域取得了顯著的技術進步,但義肢及相關醫療程序的高昂成本仍是市場擴張的一大障礙。這些設備的研發和製造成本高昂,使得世界上有很大一部分人口,特別是發展中地區的人口,難以負擔。因此,這種經濟障礙限制了低收入或醫療服務匱乏的患者獲得和廣泛使用義肢解決方案,最終阻礙了潛在的市場成長和發展機會。

全球人工器官市場趨勢

全球人工器官市場正呈現出一個顯著的趨勢,即3D列印技術在假體器官製造上的應用。這項技術進步使得為每位患者客製化器官成為可能,從而提高了複雜器官系統的精確性、功能性和生物相容性。透過簡化製造流程,3D列印顯著降低了成本和研發週期,使先進的假體器官能夠惠及更廣泛的患者群體。因此,這種創新方法正在推動市場顯著成長,吸引投資和研究,致力於開發更先進的應用,以期改善依賴人工器官系統患者的生活品質。

目錄

介紹

  • 調查目標
  • 定義
  • 市場覆蓋範圍

調查方法

  • 資訊收集
  • 二手和一手資料資訊來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 前景
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場動態
    • 促進要素
    • 機會
    • 抑制因素
    • 任務
  • 波特分析

關鍵市場考察

  • 技術分析
  • 價值鏈分析
  • 市場生態系統
  • 專利分析
  • 監管環境
  • 創新矩陣
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

按器官類型分類的人工器官市場

  • 人工腎臟
  • 人工肺
  • 人工心臟
  • 人工肝臟
  • 其他

以固定方法分類的人工器官市場

  • 嵌入式
  • 穿戴式裝置

按材料分類的人工器官市場

  • 矽酮
  • 聚氨酯
  • 其他

按最終用戶分類的人工器官市場

  • 醫院
  • 學術研究機構
  • 專科診所

按地區分類的人工器官市場規模

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲(MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭格局

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市佔率(2025 年)

主要企業簡介

  • Edwards Lifesciences Corporation
  • Cochlear Limited
  • Zimmer Biomet Holding Inc.
  • Jarvik Heart, Inc.
  • Boston Scientific Corporation
  • Berlin Heart GmbH
  • SynCardia Systems LLC
  • CARMAT
  • BiVACOR Inc.
  • AWAK Technologies
  • Wearable Artificial Organs, Inc.
  • Medtronic Plc
  • ALung Technologies, Inc.
  • Fresenius Medical Care
  • Johnson & Johnson
  • TransMedics, Inc
  • Abott
簡介目錄
Product Code: SQMIG35H2303

Global Artificial Organs Market size was valued at USD 30.75 Billion in 2024 and is poised to grow from USD 33.18 Billion in 2025 to USD 60.96 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The global market for artificial organs is witnessing significant growth driven by the rising elderly population and increased demand for organ transplants among individuals aged 65 and older. This demographic is particularly vulnerable to post-implantation complications, heightening the need for advanced prosthetic devices. As transplant waiting lists expand due to escalating patient needs, innovative initiatives aim to enhance system efficacy and accountability within organ transplant frameworks. Additionally, advancements in 3D bioprinting technology are pivotal, allowing for the creation of artificial organs that minimize rejection risks. Furthermore, the integration of artificial intelligence is set to transform manufacturing technologies, enabling tailored organ and donor assessments that facilitate patient decision-making processes regarding transplantation options. This progressive landscape highlights a burgeoning sector within the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Organs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Organs Market Segments Analysis

Global Artificial Organs Market is segmented by Organ Type, Fixation, End-User and region. Based on Organ Type, the market is segmented into Artificial kidney, Artificial liver, Artificial lungs, Artificial pancreas, Artificial heart and Other organ types. Based on Fixation, the market is segmented into Implantable and Wearable. Based on End-User, the market is segmented into Hospitals, Academic and Research Institutes and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Organs Market

The growing prevalence of chronic diseases, including kidney failure, heart disease, and liver dysfunction, significantly propels the artificial organs market. As more individuals face organ-related health challenges, the demand for prosthetic solutions-such as dialysis machines, artificial hearts, and liver support systems-continues to escalate. This trend is intensified by an aging population and a heightened focus on improving quality of life, which collectively underscore the urgent need for innovative life-saving interventions. As more patients seek effective solutions to manage their conditions, the market for artificial organs is poised for substantial growth, addressing critical healthcare needs globally.

Restraints in the Global Artificial Organs Market

Although there have been significant technological advancements in the field of artificial organs, the considerable expense associated with prosthetics and their associated medical procedures continues to hinder market expansion. The substantial costs involved in the research, development, and manufacturing of these devices render them inaccessible for a large portion of the global population, particularly in developing regions. As a result, this financial barrier restricts the availability and adoption of prosthetic solutions among patients with limited income or insufficient access to healthcare services, ultimately impeding potential market growth and development opportunities.

Market Trends of the Global Artificial Organs Market

The global artificial organs market is witnessing a significant trend driven by the integration of 3D printing technology in prosthetics. This advancement facilitates the production of customized, patient-specific organs, enhancing accuracy, functionality, and biocompatibility of complex organ systems. By streamlining manufacturing processes, 3D printing significantly reduces costs and development times, making advanced prosthetics more accessible and appealing to a broader patient demographic. As a result, this innovative approach is fostering substantial growth within the market, attracting investments and research into more sophisticated applications that promise to enhance the quality of life for individuals relying on artificial organ systems.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Patent Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Artificial Organs Market by Organ Type

  • Market Overview
  • Artificial Kidney
  • Artificial Lung
  • Artificial Heart
  • Artificial Lever
  • Others

Artificial Organs Market by Fixation

  • Market Overview
  • Implantable
  • Wearable

Artificial Organs Market by Material

  • Market Overview
  • Silicon
  • Polyurethane
  • Others

Artificial Organs Market by End User

  • Market Overview
  • Hospitals
  • Academic and Research Institutes
  • Specialty Clinics

Artificial Organs Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cochlear Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holding Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jarvik Heart, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Berlin Heart GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SynCardia Systems LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CARMAT
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BiVACOR Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AWAK Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wearable Artificial Organs, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ALung Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Medical Care
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TransMedics, Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments